Skip to content
value.today

Endostim, Inc.

🇺🇸 St. Louis, Missouri, USAHealth CareFounded 2009
Total raised
$58 M
7 rounds on record
Latest round
$12 M
Dec 2017
First round on record
Jul 2010
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Endostim, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2017$12 MNo. 7$10 to $50 million

Endostim, Inc.: Raise no. 7, Dec 2017

Investors in this round

20 investors had bought by the notice of Jan 16, 2018: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $25 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kimberly D. Pinson · Executive Officer
  • Paul K. Goode · Executive Officer
  • Rohan J. Hoare · Executive Officer, Director
  • Virender K. Sharma · Executive Officer
  • Alexander D. Schmitz · Director
  • Douglas D. French · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kimberly Pinson, Chief Financial Officer and Assistant Secretary. Source: SEC Form D and 1 amendment, newest notice filed Jan 16, 2018. Read the notice at the SEC.

equity, optionsSEC
Mar 2016$11 MNo. 6$10 to $50 million

Endostim, Inc.: Raise no. 6, Mar 2016

Investors in this round

83 investors had bought by the notice of Mar 23, 2016: 83 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $20 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bevil J. Hogg · Executive Officer, Director
  • Paul S. Goode · Executive Officer
  • Peggy S. Stohr · Executive Officer
  • Shai S. Policker · Executive Officer
  • Alexander S. Schmitz · Director
  • Douglas D. French · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peggy S. Stohr, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 23, 2016. Read the notice at the SEC.

equity, optionsSEC
May 2015$3 MNo. 5$2 to $10 million

Endostim, Inc.: Raise no. 5, May 2015

Investors in this round

1 investor had bought by the notice of May 8, 2015: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $3 M still to sell
Smallest investment taken
$2,500,003
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bevil J. Hogg · Executive Officer, Director
  • Paul G. Goode · Executive Officer
  • Peggy S. Stohr · Executive Officer
  • Shai G. Policker · Executive Officer
  • Douglas D. French · Director
  • Fred C. Goad · Director
  • Jeffrey M. McDonnell · Director
  • Ralph G. Dacey · Director
  • Raul E. Perez · Director
  • Virender K. Sharma · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peggy S. Stohr, Chief Financial Officer. Source: SEC Form D, newest notice filed May 8, 2015. Read the notice at the SEC.

equitySEC
Jun 2014$6 MNo. 4$2 to $10 million

Endostim, Inc.: Raise no. 4, Jun 2014

Investors in this round

72 investors had bought by the notice of Jul 10, 2014: 72 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $8 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$100,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bevil J. Hogg · Executive Officer, Director
  • Paul G. Goode · Executive Officer
  • Peggy S. Stohr · Executive Officer
  • Shai G. Policker · Executive Officer
  • Douglas D. French · Director
  • Fred C. Goad · Director
  • Jeffrey M. McDonnell · Director
  • Ralph G. Dacey · Director
  • Raul E. Perez · Director
  • Virender K. Sharma · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Stifel, Nicolaus & Company, Incorporated (CRD 793) · St. Louis, MissouriSold in AZ, CA, CO, CT, DC, FL, IL, KY, LA, MO, NY, SC, TN
  • Healthios Capital Markets, LLC (CRD 115542) · Northbrook, IllinoisSold in AZ, CA, CO, CT, DC, FL, IL, KY, LA, MO, NY, SC, TN

Signed by Peggy S. Stohr, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 10, 2014. Read the notice at the SEC.

debt, optionsSEC
Dec 2012$14 MNo. 3$10 to $50 million

Endostim, Inc.: Raise no. 3, Dec 2012

Investors in this round

81 investors had bought by the notice of May 29, 2013: 81 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $17 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$544,407
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bevil J. Hogg · Executive Officer, Director
  • Peggy S. Stohr · Executive Officer
  • Douglas D. French · Director
  • Fred C. Goad · Director
  • Jeffrey M. McDonnell · Director
  • Ralph G. Dacey · Director
  • Raul E. Perez · Director
  • Virender K. Sharma · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Stifel, Nicolaus & Company, Incorporated (CRD 793) · St. Louis, MissouriSold in AZ, CA, CO, CT, DC, FL, IL, KY, LA, MA, MO, SC, TN, TX

Signed by Peggy S. Stohr, Chief Financial Officer. Source: SEC Form D and 4 amendments, newest notice filed May 29, 2013. Read the notice at the SEC.

equitySEC
Nov 2011$6 MNo. 2$2 to $10 million

Endostim, Inc.: Raise no. 2, Nov 2011

Investors in this round

10 investors had bought by the notice of Dec 5, 2011: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bevil J. Hogg · Executive Officer, Director
  • Peggy G. Stohr · Executive Officer
  • Doug K. French · Director
  • Fred K. Goad · Director
  • Jeffrey K. McDonnell · Director
  • Ralph G. Dacey · Director
  • Raul E. Perez · Director
  • Virender K. Sharma · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peggy S. Stohr, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 5, 2011. Read the notice at the SEC.

equitySEC
Jul 2010$6 MNo. 1$2 to $10 million

Endostim, Inc.: Raise no. 1, Jul 2010

Investors in this round

26 investors had bought by the notice of Jul 30, 2010: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bevil J. Hogg · Executive Officer, Director
  • Doug E. French · Director
  • Fred E. Goad · Director
  • Jeffrey E. McDonnell · Director
  • Raul E. Perez · Director
  • Sarah E. Sharma · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Raul E. Perez, Chairman of the Board of Directors. Source: SEC Form D, newest notice filed Jul 30, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Endostim, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2018).

    SEC Form D · Jan 2018

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2018

That is all the official record says: Endostim, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Endostim, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 83 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Endostim, Inc.
NameRoleNamed in
Kimberly D. PinsonExecutive officerJan 2018
Paul K. GoodeExecutive officerJan 2018
Rohan J. HoareExecutive officerJan 2018
Virender K. SharmaExecutive officerJan 2018
Kimberly S. PinsonExecutive officerJan 2018
Bevil J. HoggExecutive officerMar 2016
Paul S. GoodeExecutive officerMar 2016
Peggy S. StohrExecutive officerMar 2016
Shai S. PolickerExecutive officerMar 2016
Paul G. GoodeExecutive officerMay 2015
Shai G. PolickerExecutive officerMay 2015
Peggy G. StohrExecutive officerDec 2011
Alexander D. SchmitzDirectorJan 2018
Douglas D. FrenchDirectorJan 2018
Rohan J. HoareDirectorJan 2018
Alexander S. SchmitzDirectorJan 2018
Bevil J. HoggDirectorMar 2016
Fred C. GoadDirectorMay 2015
Jeffrey M. McDonnellDirectorMay 2015
Ralph G. DaceyDirectorMay 2015
Raul E. PerezDirectorMay 2015
Virender K. SharmaDirectorMay 2015
Doug K. FrenchDirectorDec 2011
Fred K. GoadDirectorDec 2011
Jeffrey K. McDonnellDirectorDec 2011
Doug E. FrenchDirectorJul 2010
Fred E. GoadDirectorJul 2010
Jeffrey E. McDonnellDirectorJul 2010
Sarah E. SharmaDirectorJul 2010